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Objectives: Undifferentiated embryonic cell transcription factor-1 (UTF1) plays a critical role in the developmental
timing during embryonic development. However, there is little paper dealing with UTF1 expressed in adult tissues.
In the present study, we evaluate the expression of UTF1 in breast cancer and its correlation with clinicopathological
parameters.
Methods: Real-time polymerase chain reaction (real-time PCR) was applied to detect the expression of UTF1 mRNA in
the 55 pairs of samples of breast cancer tissues and match normal tissues. △△CT method was used to evaluate the
relative quantity of target mRNA expression.
Results: Among the 55 pairs of samples of breast cancer tissues and match normal tissues adjacent to the tumor, the
UTF1 mRNA levels in normal tissues were significantly higher than those observed in breast cancer tissues (p < 0.001).
UTF1 mRNA levels expression correlated with lymph node metastasis (p = 0.002) and tumor size (p < 0.001).
Conclusions: Expression of UTF1 in breast cancer tissues were confirmed in this study. Decreased expression of UTF1
mRNA in breast cancer tissues was maybe one of the factors impact on tumorigenes in breast cancer patients.
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Currently breast cancer remains one of the most
common cancers worldwide, and one of the leading
causes of cancer related death in the word. Identification
of biological markers ability to predict risk of prognosis in
breast cancer is limited. To improve the clinical outcome
of patients with advanced breast carcinoma, it is necessary
to target novel biomarker genes, which appear to be
involved in carcinoma development, as we had described
previously [1,2].
Previous reports have indicated that there was a pos-
sible correlation of undifferentiated embryonic cell tran-
scription factor-1 (UTF1) with the biological of cancer
cell [3]. And the low expression of UTF1 may connect
with poorer prognosis among patients with cervical
cancer [4].* Correspondence: mtybb2010@163.com; cwzjsx5018@163.com
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(UTF1), a transcriptional co-activator, was first isolated
and identified from mouse F9 embryonic carcinoma cells
[5]. The human UTF1 gene is located on chromosome
10q26 and consists of two exons and one short intron,
which plays a critical role in the developmental timing
during embryonic development [6,7]. UTF1 is readily
expressed in embryos and embryonic stem cells, but it is
either undetectable or its expression remains at low
levels in normal adult tissues, suggesting that UTF1 may
play a critical role in cell proliferation and/or differenti-
ation during embryonic development.
Recently, UTF1 confirmed the ability to facilitate the
reprogramming of human somatic cells to induced pluri-
potent stem (iPS) cells [8]. Thus, UTF1 plays an import-
ant role in stem cells, and the expression of UTF1
cancer cells may have stem cell-like features. This
prompted us to evaluate UTF1 status in human beast
cancer. In addition, UTF1 has been reported to bind to aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinicopathologic characteristics of 55 cases of
patients with breast cancer
Clinicopathologic parameter Case (n) %
Age
≦ 35 5 9.1%
> 35 50 90.9%
Tumor size (cm)
≦ 2 36 65.5%





ER (+)/PR (+) 23 41.8%
ER (+)/PR (−) 7 12.7%
ER (−)/PR (+) 4 7.3%




Table 2 Relative quantity of UTF-1 mRNA in breast cancer
tissues and match normal tissues
Tumor tissue Normal tissues P
Relative UTF-1 expression 1.97 ± 0.161 7.47 ± 1.01 <0.001
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lations, including those for p27 and Oct-3/4 [9].
The expression of UTF1 was subsequently detected in
germ cell neoplasms [10], and cervical cancer [4]. Al-
though UTF1 has been extensive studied in other cancers,
no investigation has been conducted in breast cancer. We
hypothesize that UTF1 may play a role in the oncogenesis
of breast cancer. The present study was undertaken to
examine the expression of UTF1 in breast cancer tissues
by using a validated specific and sensitive real-time quan-
titative PCR assay. Here, we examined fifty-five cases of
breast cancer tissues for the potential difference of UTF1
expression in breast cancer tissues and their matched nor-
mal tissues, and to assess the relationship between UTF1




Specimens were obtained from 55 patients who under-
went surgery of breast cancer at the Department of
Breast and Thyroid Surgery of Shaoxing Hospital of
Zhejiang University, between July 2012 and November
2013. Informed consent was obtained from all patients,
and the study was conducted according to the guidelines
of the Hospital Ethics Committee. The patients aged 35
to 73 years (mean 58.7 years). The correlation between
the expression of UTF1 and clinicopathologic parame-
ters including age, differentiation statue and pTNM
pathological classification according to the International
Union against Cancer (UICC) were evaluated. The clini-
copathologic feature of the 55 cases were summarized in
Table 1.
RNA extraction and cDNA synthesis
Total RNA was extracted from fleshly frozen gastric tis-
sues using the Trizol reagent (Invitrogen life Technologies,
USA). Total RNA was reverse reverse-transcribed into
single-strand complementary DNA (cDNA) using moloney-
murine leukemia (M-MLV) reverse transcriptase (Promega,
Madison,WI, USA). Briefly, the RNAwas denatured
by heating for 5 min at 70°C, cooled on ice, and then
used for reverse transcription (2 μg of total RNA,
25U of RNAse inhibitor, 0.5 mM each of dNTPs, 1.5 μM
reverse primer and 200U of M-MLV reverse transcript-
ase in a total volume of 25 μl). For reverse transcription,
tubes were incubated at 42°C for 60 min, followed by
rapid cooling.
Real-time quantitative PCR
Real-time RT-PCR analyses were performed with the ABI
Prism 7500 sequence detection system (Applied Biosystems,
Foster City, CA). 25 μl reaction mixture containing 2 μl of
cDNA template, 1 μl each of sense and anti-sense primers,1 × SYBR Green Universal PCR Mix was amplified as
follow: denaturation at 95°C for 10 min and 40 cycles at
95°C for 30 s, 55°C for 30 s and 72°C for 40 s. Real-time
quantitative PCR reaction was performed in triplicate for
each sample and a mean value of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) used to calculate
mRNA levels. Quantitative analysis was performed using
the comparative CT method [11,12]. The UTF-1 mRNA
copy numbers in normal and tumor tissues were normal-
ized to mRNA copy numbers of the house keeping
gene, GAPDH to give a value △CT. This final value
was to determine changes in expression of UTF-1 in each
sample. The primer sequences for UTF-1 were as follows:
forward primer 5'- ATGGGGCTGCTGGGCGACAAC
G-3', reverse primer 5'- GGGGAGGCGTCCGCAGAC
TTCG-3'. The primers for GAPDH were taken from a
previously published assay [13]. Fluorescent data were
converted into RQ measurements, which stand for rela-
tive expression automatically by the SDS system soft-
ware and exported to Microsoft Excel. Thermal dissociation
plots were examined for biphasic melting curves, indi-
cative of whether primerdimers or other nonspecific
products could be contributing to the amplification
signal.
Table 3 Correlation between the expression of UTF-1








0.33 ± 0.56 1.75 ± 2.12 p = 0.002
Tumor size 1.34 ± 0.60 2.46 ± 1.28 (p <0.001)
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Statistical analysis was conducted using the statistical
program SPSS 15.0 for Windows (SPSS, Chicago, IL, USA).
Pre-treatment characteristics were analyzed using the
2-tailed χ2 test. The 2-tailed t-test was used to evalu-
ate the correlation between UTF-1 expression and clinico-
pathologic parameters.
Results
Expressions of UTF-1 mRNA in breast cancer tissues by
real-time PCR
As shown in Table 2, of the 55 samples of breast cancer
tissues and matched normal tissues adjacent to the tumor,
expression of UTF-1 was detected in total samples. In
normal tissues, the UTF-1 mRNA levels ranged from
0.039 to 41.96 with a median of 20.16. In breast cancer tis-
sues, the UTF-1 mRNA levels ranged from 0.008 to 6.263
with a median of 1.517. The UTF-1 mRNA levels in nor-
mal tissues were significantly higher than those observed
in breast cancer tissues (p < 0.001).
Correlation between UTF-1 and clinicopathological
parameter
According to median expression level of UTF-1, 55 cases
of breast cancer patients were divided into two groups, high
UTF-1 expression group (UTF-1 expression level >1.517)
and low UTF-1 expression group (UTF-1 expression
level ≦ 1.517). The mean number of metastasis lymph
nodes in high UTF-1 group is lower than low UTF-1
expression group (0.33 vs. 1.75), the differences among
them had statistically significant (p = 0.002) (Table 3).
Moreover, tumor size was different between high expres-
sion UTF-1 versus low expression UTF-1 (1.34 vs. 2.46),
the difference also have statistically significant (p < 0.001)
(Table 3).
Discussion
In the present study, we found the relative quantity of
UTF-1 mRNA mRNA in 55 samples of breast cancer tis-
sues as determined by real-time PCR. UTF-1 mRNA was
expressed more predominantly in normal tissues adjacent
to the tumor than it was expressed in breast cancer
tissues. We showed that UTF-1 was lower expressed in
breast cancer tissues than corresponding normal tissues.
Previous studies have reported that UTF-1 is expressed in
various human epithelial-type neoplasias, such as cervicalcancer [4]. At present, Mouallif et al. evaluated UTF1
expression levels immunohistochemically in eight normal
epithelia including breast (prostate, endometrium, bladder,
colon, oesophagous, lung and kidney) and their corre-
sponding tumors in a recent paper [14].
In the current study, real-time quantitative PCR was
used to compare the expressions of UTF-1 mRNAs in 55
breast cancers and their matched normal tissues, which al-
lows detecting UTF-1expression in breast tissues with very
low level. Furthermore, we correlated these findings with
the clinicopathological parameter of the breast cancers.
The result showed that the low expression level of UTF-1
mRNAs in breast cancer patients was significantly associ-
ated with metastasis lymph nodes and tumor size. Our
present study clarify that UTF-1 protein could act as a po-
tential biomarker for prognosis assessment of breast can-
cer. Related mechanism is worthy of further investigation.
Previous studies have shown the expression of UTF-1
cells was identified in a subpopulation of stem cell-like
cells [15] and the expression of UTF-1 may influence the
susceptibility of cancer cells to chemotherapeutic agents
and radiotherapy. These data suggested that positive ex-
pression of UTF-1 impact on cancer patients’ survival not
only influence the susceptibility of cancer cells to chemo-
therapeutic agents, but also other mechanism such as cell
proliferation [16], stem cell-like features [17,18].
Recently, it was reported that the UTF1-overexpressing
cells transactived p27Kip1 resulting in G1/S arrest, which
may provide an explanation for UTF1 functions in cervical
carcinogenesis. The similar results may present in breast
cancer patients. In summary, our study demonstrated that
the expression level of UTF1 may play a role in the onco-
genesis and may serve as a biomarker for prognosis. Based
on our findings, UTF1 gene could be a potential target for
the treatment of breast cancer. The findings of this study
present a novel knowledge of UTF1 and a potential future
prospect for breast cancer treatment.
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